Annexon Inc (ANNX)
4.46
-0.09
(-1.98%)
USD |
NASDAQ |
Apr 23, 16:00
4.92
+0.46
(+10.31%)
After-Hours: 19:33
Annexon Shareholders Equity (Quarterly): 250.56M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 250.56M |
| September 30, 2023 | 156.84M |
| June 30, 2023 | 184.72M |
| March 31, 2023 | 214.86M |
| December 31, 2022 | 231.19M |
| September 30, 2022 | 260.60M |
| June 30, 2022 | 168.04M |
| March 31, 2022 | 200.61M |
| December 31, 2021 | 231.91M |
| Date | Value |
|---|---|
| September 30, 2021 | 264.48M |
| June 30, 2021 | 295.34M |
| March 31, 2021 | 321.48M |
| December 31, 2020 | 344.28M |
| September 30, 2020 | 365.48M |
| June 30, 2020 | 117.18M |
| March 31, 2020 | 31.84M |
| December 31, 2019 | 43.53M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
31.84M
Minimum
Mar 2020
365.48M
Maximum
Sep 2020
216.64M
Average
231.19M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Trxade Health Inc | 11.56M |
| P3 Health Partners Inc | 142.13M |
| Arrowhead Pharmaceuticals Inc | 160.41M |
| Insmed Inc | -331.92M |
| Heron Therapeutics Inc | -33.97M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 297.67M |
| Total Liabilities (Quarterly) | 47.12M |